196
0
0
Like?
Please wait...
About This Project
We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.
More Lab Notes From This Project
Browse Other Projects on Experiment
Related Projects
Developing a low-cost, rapid diagnostic for urogenital Schistosomiasis infection
We are developing a frugal diagnostic for urogenital schistosomiasis, a neglected tropical disease that...
How do cataracts form and how can they be prevented?
Cataract is the leading cause of blindness worldwide. The lens in our eye is important for focusing images...
Why does our body produce one of the most potent hallucinogens?
Our bodies produce very low doses of N,N-Dimethyltryptamine (DMT), a psychotropic substance. Recent findings...